Skip to main content
OpenTrials

Clinical trial condition

Hepatocellular Carcinoma

Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

1,013 public trials 264 recruiting studies
Refine in advanced search Browse all conditions

Hepatocellular Carcinoma trial results

Active, Not Recruiting

TheraSphere With Durvalumab and Tremelimumab for HCC

NCT05063565

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • University of Arizona- Banner Health Tucson, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery

NCT06204159

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pennsylvania, Department of Radiology, Interventional Radiology Division Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma

NCT02519348

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site San Francisco, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Jacksonville, Florida, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma

NCT06084884

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Orange, California, United States
  • Research Site San Francisco, California, United States
View all 18 locations
View Trial Details

Related conditions